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Abstract - The purposes of this research were to determine the prevalence of dengue virus in the study population, to 
determine the relationship between the occurrence of dengue virus IgM and potential risk factors and to determine the 
association between the occurrence of dengue virus and some symptoms. In this study, blood specimen were collected 
from 340 subjects with febrile complaints attending hospitals in Kaduna metropolis, Nigeria and who gave their 
consent to participate. Serological determination of dengue virus IgM was carried out using enzyme linked 
immunosorbent assay technique. Structured questionnaires were also administered to obtain data on demographic, risk 
factors,  and symptoms of illness. A total of 6 subjects were positive for dengue virus IgM giving a prevalence of 1.8%. 
There was no statistically significant association between the occurrence of dengue virus IgM and potential risk factors, 
demographic factors and symptoms of the illness. The occurrence of dengue virus in the study population was 
confirmed. 
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Introduction  
The dengue virus is single stranded, positive sense RNA virus which belong to the family 
Flaviviridae, genus Flavivirus (Gubler, 1997; Rodenhuis-Zybert et al., 2010). Other members of the 
same genus include yellow fever virus, West Nile virus, St. Louis encephalitis virus, Japanese 
encephalitis virus, tick-borne encephalitis virus, Kyasanur forest disease virus, and Omsk 
haemorrhagic fever virus (Gould and Solomon, 2008). Most are transmitted by arthropods 
(mosquitoes or ticks); therefore, also referred to as arboviruses (arthropod-borne viruses) (Gould 
and Solomon, 2008). The clinical outcomes of dengue virus infection could vary from 
asymptomatic, mild febrile dengue fever (DF) to severe and life threatening dengue haemorrhagic 
fever (DHF)/dengue shock syndrome (DSS) (Gunther et al., 2007). 
Typically, people infected with dengue virus are asymptomatic (80%) or only have mild 
symptoms such as an uncomplicated fever (WHO, 2009; Whitehorn and Farrar, 2010). Others have 
more severe symptoms (5%), and in a small proportion it is life-threatening (Whitehorn and Farrar, 
2010; Reiter, 2010). The incubation period ranges from 3–14 days, but most often is 4–7 days 
(Gubler, 2010). Therefore, travellers returning from endemic areas are unlikely to have dengue if 
fever or other symptoms start more than 14 days after arriving home (Ranjit and Kissoon, 2010). 
Children often experience symptoms similar to those of the common cold and gastroenteritis 
(Varatharaj, 2010) but are more susceptible to the severe complications (Ranjit and Kissoon, 2010). 
Dengue has emerged in recent decades and become a worldwide public problem, 
particularly in Asia-Pacific and Americas-Caribbean regions (Gubler and Clark, 1995; Gubler, 2004; 
Halstead, 2008). In Africa, the epidemiology and public health effects of dengue is not clear 
(Amarasinghe et al., 2011). Aedes spp. mosquitoes are widely distributed in Africa and can serve as 
vectors of dengue virus (Amarasinghe et al., 2011). When their distribution is combined with rapid 
population growth, unplanned urbanization and increase in international travel, extensive 
transmission of dengue virus is likely in Africa (Gubler, 2004; United Nations, 2009). Over the past 
five decades, cases of epidemic or sporadic dengue have been reported in sub-Saharan Africa 
(WHO, 2009). Although sporadic cases of DHF have been reported in a few countries in Africa, 
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no outbreaks have been reported (Gubler and Clark, 1995). However, when compared with the 
Asia-Pacific and Americas-Caribbean regions, the epidemiology of dengue in Africa has not been 
defined.  
A study in Nigeria determined the prevalence of flavivirus infection among 1,816 children 
and adults in urban and rural areas from samples were collected mainly during the early 1970s 
(Fagbami et al., 1977). Virus-specific haemagglutination inhibition testing showed that the 
prevalence of immunity was 38% for dengue virus-1 infection, 45% for dengue virus-1 infection, 
43% for yellow fever virus infection and 49% for West Nile virus infection (Fagbami et al., 1977). 
Serum specimens were also tested by suckling mouse neutralization of dengue virus – 2. The 
authors concluded that because a high proportion of specimens with antibody to dengue virus – 2 
were confirmed by neutralization and because many had only monotypic antibody, the prevalence 
results were not likely confounded by cross-reactive antibodies to other flaviviruses. Another study 
by Baba et al. (2009) revealed the prevalence of dengue virus IgG in rain forest and wooded 
savannah areas of Nigeria was 69.0%. In addition, the study by Fagbemi et al. (1977) showed an 
increase in prevalence of antibodies against dengue virus with age. These suggest endemic 
infection. 
 
Materials and Methods 
Study area 
Kaduna State occupies part of the central position of the northern part of Nigeria (with 
Kaduna as its capital) and shares boundaries with Niger State to the west, Zamfara, Katsina and 
Kano states to the north, Bauchi and Plateau states to the east and FCT Abuja and Nasarawa State 
to the south. Kaduna State lies at latitude 10°20′ north and longitude 7°45′ east. The state occupies 
an area of approximately 48,473.2 square kilometres and has a population of more than 6 million 
people (KGIS, 2008). Four hospitals were selected from Kaduna metropolis and used for the 
study.  
Study population and ethical clearance 
Referred-patients with febrile illnesses who sent to the laboratory for malaria test were 
recruited for the study.  Ethical consent was sought and obtained from the ethical committee of 
Kaduna State Ministry of Health and from all hospitals in this research. 
Inclusion and exclusion criteria 
Patients attending the hospital during the period of the research who were referred to the 
hospital laboratory for malaria test and who gave their consent to participate were included in 
study. Non febrile patients and patients referred for malaria test who did not give their consent to 
participate in the study were excluded.   
Sample collection  
A total of 340 serum samples were collected from febrile patients. About 5ml of blood was 
collected by venipuncture. The blood was allowed to clot at room temperature and the serum was 
carefully collected after centrifugation at 2,000 rpm for 10 minutes and stored at –4ºC for further 
analysis. 
Detection of dengue virus IgM and determination of risk factors associated with dengue 
virus infection 
An IgM capture ELISA (MAC–ELISA) as previously described by Vorndam and Kuno 
(1977) was used for dengue virus IgM detection. A set of standard questionnaire was used to 
collect demographic data, clinical history and dengue risk factors. The questionnaires were divided 
into three sections. Section A required demographic such as age, gender, highest educational level 
attained, marital status and occupation from the patients. Section B required some clinical data 
such as symptoms of fever, headache, muscle and joint pains, cold, abdominal discomfort, 
diarrhoea, vomiting and rash. Section C attempted to uncover the exposure of the patients to risk 
factors such as use of mosquito nets, use of insecticides, presence of gutters or bushes close to 
residential area, sleeping in the afternoon, leaving of doors open in the early mornings and 
evenings, frequency of anti-malaria drug use and current use of anti-malaria drug predisposing to 






dengue virus infection. The questionnaire was administered using the discussion method during 
which the researcher asks the patients questions contained in the questionnaire and thick as 
appropriate. The information gathered was recorded. 
 
Results and Discussion  
Prevalence of dengue virus  
Figure 1 presents the prevalence of dengue virus IgM in the study population. Out of the 
340 samples studied, 6 (1.8%) patients were sero-positive for dengue virus IgM and 334 samples 
(98.2%) were sero-negative for dengue virus. Although, the prevalence of dengue virus IgM 
obtained in this study was quite low, it has brought to lime light the occurrence of the virus within 
Kaduna metropolis, Nigeria. A positive case of dengue virus in a community is epidemiologic 
importance as mosquitoes can transmit the virus from an infected person to a high proportion of 
susceptible individuals within the same environment. The result of this study is in line with 
previous studies by Dawurung et al. (2010) with a prevalence of 2.2% and Baba et al. (2009) with 
prevalence of 0.67%. 
Relationship between occurrence of dengue virus IgM and potential risk factors  
The relationships between some potential risk factors and the occurrence of dengue virus 
IgM in the study population are presented in Table 1. The risk factors considered including the use 
of mosquito bed net, the use of insecticides, presence of gutters or bush around house, sleeping in 
the afternoon, and the use of insecticide/bed net in the afternoon. There was no significant 
association between the presence of these factors and the occurrence of dengue virus IgM 
(p>0.05). However, odds ratio analysis shows that those who did not use mosquito bed nets at 
night are at 1.275 times more likely to be infected with dengue virus than those who use. Patients 
with gutters and/or bush close to their residential areas are 1.3 times likely to get dengue virus 
infection (Table 1). The relationship between the occurrence of the dengue virus IgM and risk 
factors was not significant as their p-values were greater than 0.05. This could be due to the fact 
that the total number of the study samples infected with dengue virus was quite small.  
 
Table 1. Relationship between the occurrence of dengue virus IgM and  
potential risk factors 
 
Risk factors 
Dengue virus IgM 
Total Positive(%) Negative(%) p-value OR CI 95% 
Use of mosquito net       
No 208 4(1.9) 204(98.1) 0.781 1.275 0.230-7.058 
Yes 132 2(1.5) 130(98.5)    
Use of insecticides        
No 120 2(1.7) 118(98.3) 0.919 0.951 0.165-5.071 
Yes 220 4(1.8) 216(98.2)    
Gutters/bush around 
house 
      
Yes 205 4(2.0) 201(98.0) 0.748 1.323 0.239-7.328 
No 135 2(1.5) 133(98.5)    
Sleep in the afternoon       
Yes 245 4(1.6) 241(98.4) 0.766 0.772 0.139-4.285 
No 95 2(2.1) 93(97.9)    
Use of insecticides in the 
afternoon 
      
No 218 3(1.4) 215(98.6) 0.368 0.363 0.036-3.617 
Yes 27 1(3.7) 26(96.3)    
Note: OR = odds ratio,  CI = Confidence interval 
 
Primary protection against infection with dengue virus depends on the control of 
mosquitoes (Mahyoub et al., 2013). Such control measures include the use of insecticide treated 
mosquito bed nets, spraying of insecticides and other measures to reduce the reproduction and 
multiplication of mosquito vectors of disease and reduce their number in the environment to the 






extent that they do not spread disease (WHO, 1990). In Africa, Aedes aegypti breeds primarily in 
natural containers such as trees, holes and leaf axils and artificial containers (Rozendaal, 1997). 
Therefore, the need for effective environmental management cannot be overemphasized. 
Insecticide treated bed nets can be effectively used to protect infants and night workers while 
sleeping in day time since the vector specie bite during the day time, early morning or late 
afternoon. 
Relationship between the occurrence of dengue Virus IgM and demographic factors 
The relationship between the occurrence of dengue virus IgM and demographic factors are 
presented in Tables 2 to 4. The demographic factors considered including age, gender, highest 
educational level attained, marital status, and occupation. There was no significant association 
between the occurrence of dengue virus IgM and these demographic factors (p>0.05). However, 
odds ration analysis shows that, age group 41-50 was 1.605 times more likely of having dengue 
virus IgM than other age groups (Table 3). Females were 2.877 times more likely to have dengue 
virus IgM positive than males. Considering highest educational level attained, patients with primary 
education were at 2.430 times more likely to have dengue virus IgM positive compared with those 
with other levels of education (Table 4.). According to marital status, those who were married had 
the likelihood of 2.048 times of being dengue cases than those who were single and widowed 
(Table 4).  
The relationship between the occurrence of dengue virus IgM and occupation was not 
significant (Chi-square = 3.081 and p = 0.379) (Table 4). Dengue infection is not peculiar to any 
age group or sex (Dawurung et al., 2010) indicating that everyone is at risk of contracting the 
disease. However, with regards to gender distribution, the prevalence of dengue virus IgM in 
females (2.3%) was higher than that of males (0.8%) and odds ratio analysis shows that females 
were 3 times more likely to come down with dengue virus infection than males. This could be due 
to the fact that Aedes sp breeds in human dwelling and surroundings and women are more likely to 
remain in and around the home, carrying out domestic activities during the day when the 
mosquitoes are most active, feeding indoors and outdoors. This agrees with previous research by 
Shu-yuan, (2007), Dawurung et al. (2010), and Idris et al. (2010). With regards to highest educational 
level attained, those with tertiary education had the least percentage occurrence of dengue virus 
IgM (0.0%). Dengue transmission by Aedes aegypti has been associated with poor hygienic 
conditions, which in turn may be associated with low socio economic levels and to low schooling 
of the house dwellers (Rodriguez-Figueroa et al., 1995). In Kenya, the use of insecticide-
impregnated bed nets was significantly related to mother’s educational level (Marsh et al., 1996). 
 
Table 2. Relationship between the occurrence of dengue virus IgM and demographic  
factors (age and gender) 
Demographic Factors Dengue virus IgM 
Total Positive (%) Negative (%) P-value OR C.I. 
Age       
1 – 10 66 1(1.5) 65(98.5) 0.864 0.828 0.095-7.206 
Others 274 5(1.8) 269(98.2)    
11 – 20 56 1(1.8) 55(98.2) 0.990 1.015 0.116-8.854 
Others 284 5(1.8) 279(98.2)    
21 – 30 87 1(1.1) 86(98.9) 0.613 0.577 0.066-5.006 
Others 253 5(2.0) 248(98.0)    
31 – 40 54 1(1.9) 53(98.1) 0.958 1.060 0.121-9.259 
Others 286 5(1.7) 281(98.3)    
41 – 50 38 1(2.6) 37(97.4) 0.667 1.605 0.183-14.118 
Others 302 5(1.7) 297(98.3)    
>50 39 1(2.6) 38(97.4) 0.687 1.558 0.177-13.691 
Others 301 5(1.7) 296(98.3)    
Gender       
Female 217 5(2.3) 212(97.7) 0.316 2.877 0.332-24.914 
Male 123 1(0.8) 122(99.2)    
Note:  OR = odds ratio,  C.I. = Confidence interval 







Table 3. Relationship between the occurrence of dengue virus IgM and some  
demographic factors (educational level and marital status) 
Demographic 
factors 
Dengue virus IgM 
Total Positive(%) Negative(%) p-value OR CI 95% 
Educational level       
Tertiary 65 0(0.0) 65(100.0) 0.230   
Others 275 6(2.2) 269(97.8)    
Secondary 105 2(1.9) 103(98.1) 0.896 1.121 0.202-6.220 
Others 235 4(1.7) 231(98.3)    
Primary 59 2(3.4) 57(96.6) 0.297 2.430 0.435-13.585 
Others 281 4(1.4) 277(98.6)    
Quranic 55 1(1.8) 54(98.2) 0.974 1.037 0.119-9.053 
Others 285 5(1.8) 280(98.2)    
Informal 56 1(1.8) 55(98.2) 0.990 1.015 0.116-8.854 
Others 284 5(1.8) 279(98.2)    
Marital Status       
Single 163 2(1.2) 161(98.8) 0.470 0.537 0.097-2.973 
Others 177 4(2.3) 173(97.7)    
Married 169 4(2.4) 165(97.6) 0.402 2.048 0.370-11.336 
Others 171 2(1.2) 169(98.8)    
Widowed 8 0(0.0) 8(100.0) 0.701   
Others 332 6(1.8) 326(98.2)    
   Note: OR = odds ratio,  CI = Confidence interval 
 
Table 4. Relationship between the occurrence of dengue virus IgM and occupation 
Demographic factor Dengue virus IgM 
Total Positive(%) Negative(%) Chi-square P-value 
Occupation      
Civil servant 29 0(0.0) 29(100.0)   
Self employed 32 0(0.0) 32(100.0)   
Military 53 0(0.0) 53(100.0)   
Others 226 6(2.7) 220(97.3) 3.081 0.379 
 
Occurrence of dengue virus in relation to some symptoms 
The relationships between the occurrence of dengue virus IgM and some symptoms were 
also assessed. The symptoms include fever, headache, muscle and joint pains, cold, abdominal 
discomfort, diarrhoea, vomiting and rash. The association between the occurrence of dengue virus 
IgM and the presence of these symptoms in the study population was not significant (p>0.05). 
However, odds ratio analysis revealed that the 253 patients with fever were at 1.743 odds of having 
dengue virus IgM than those without fever. One hundred and seventy seven patients with 
abdominal discomfort were at 1.861 odds of being dengue cases than those who did not have 
abdominal discomfort. The 55 patients with diarrhoea were 2.651 times more likely to be dengue 
cases than those who do not have diarrhoea (Table 5). People with fever, diarrhoea and abdominal 
discomfort had higher percentage occurrences of dengue virus IgM positive and were more likely 
to have dengue virus IgM than those who did not display these symptoms. Similar clinical 
manifestations have been reported in different studies (Ayyub et al., 2006; Shahin et al., 2009). This 
is of immense public health importance because people who present with these symptoms at clinics 













Table 5. Occurrence of dengue virus IgM in relation to some symptoms 
 
Symptoms 
Dengue virus IgM 
Total Positive(%) Negative(%) p-value OR CI 95% 
Fever       
Yes 253 5(2.0) 248(98.0) 0.613 1.743 0.200-15.050 
No 87 1(1.1) 86(98.9)    
Headache       
Yes 241 4(1.7) 237(98.3) 0.819 0.819 0.147-4.543 
No 99 2(2.0) 97(98.0)    
Muscle and joint pains 
Yes 220 4(1.8) 216(98.2) 0.919 1.093 0.197-6.054 
No 120 2(1.7) 118(98.3)    
Cold       
Yes 142 1(0.7) 141(99.3) 0.208 0.274 0.032-2.369 
No 198 5(2.5) 193(97.5)    
Abdominal discomfort 
Yes 177 4(2.3) 173(97.7) 0.470 1.861 0.336-10.300 
No 163 2(1.2) 161(98.8)    
Diarrhoea       
Yes 55 2(3.6) 53(3.6) 0.250 2.651 0.473-14.842 
No 285 4(1.4) 281(98.6)    
Vomiting       
Yes 74 1(1.4) 73(98.6) 0.760 0.715 0.082-6.217 
No 266 5(1.9) 261(98.1    
Rash       
Yes 7 0(0.0) 7(100.0) 0.720   
No 333 6(1.8) 327(98.2)    
     Note: OR = odds ratio, CI = Confidence interval 
 
Conclusions  
In this study, the occurrence of dengue virus in the study population has been confirmed. 
Therefore, as the clinical symptoms associated with dengue virus infection are indistinguishable 
from many other febrile illnesses such as malaria, typhoid, and other virus diseases; therefore, 
specific diagnostic tests assume critical importance in the identification of febrile illnesses within 
the study area. 
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